We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SOUN:NASDAQSoundHound AI, Inc. Analysis

Data as of 2026-06-03 - not real-time

$8.15

Latest Price

8/10Risk

Risk Level: High

Executive Summary

SoundHound AI’s price is trading below its long‑term moving average while the short‑term average sits modestly above the intermediate average, indicating a mixed short‑term bias but a broader downtrend. Momentum indicators sit in neutral territory with the RSI under the midpoint and the MACD histogram turning negative, and trading volume has been slipping, all against a backdrop of very high recent price volatility and a beta that far exceeds the market, pointing to heightened systematic risk.
Fundamentally, the company delivered a striking revenue surge of over fifty percent year‑over‑year, yet profitability remains deeply negative with operating and net margins in the double‑digit loss range. The balance sheet shows ample cash relative to minimal debt, but cash burn persists and free cash flow is still negative. No dividend is paid, and valuation multiples such as price‑to‑sales and price‑to‑book are elevated, suggesting the market is pricing in aggressive growth expectations despite the earnings shortfall. Analyst sentiment skews strongly bullish with a sizable upside target, while market sentiment is in an extreme greed phase.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • recent earnings miss and price decline
  • bearish MACD and decreasing volume
  • high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • robust revenue growth momentum
  • strong cash position relative to debt
  • analyst upside expectations

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • expanding AI voice market and platform differentiation
  • continued top‑line growth trajectory
  • sufficient liquidity to fund further development

Key Metrics & Analysis

Financial Health

Revenue Growth51.70%
Profit Margin-91.84%
P/E Ratio-67.9
ROE-39.40%
ROA-19.67%
Debt/Equity1.35
P/B Ratio7.5
Op. Cash Flow$-105295000
Free Cash Flow$-16690625
Industry P/E42.9

Technical Analysis

TrendNeutral
RSI46.7
Support$7.85
Resistance$9.72
MA 20$8.57
MA 50$7.87
MA 200$11.25
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Target Price$14.00
Upside/Downside71.78%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta3.16
Volatility81.02%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.